Of the various challenges facing obesity drug and device developers, 31 percent of respondents to an ICON survey considered issues associated with clinical trials as top on their list. Speak with ...
Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
For the first time in a decade, adult obesity in the United States dropped last year, a new study has found, and researchers are curious how the rise in popularity of weight loss drugs like ...
Obesity rates in the United States have finally started to show a decline, heading in the right direction for the first time in a decade likely due to the popularity of weight loss drugs like ...